Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
NASDAQ: PBPH · Real-Time Price · USD
25.82
+0.26 (1.02%)
At close: Apr 1, 2026, 4:00 PM EDT
25.82
0.00 (0.00%)
After-hours: Apr 1, 2026, 4:15 PM EDT
PBPH Holdings Information
PBPH is an equity ETF with a total of 67 individual holdings. The top holdings are Eli Lilly and Company stock at 12.31%, Johnson & Johnson at 9.60%, AbbVie at 6.14%, Merck & Co. at 4.90%, and Novartis AG at 4.67%.
Total Holdings
67
Top 10 Percentage
59.59%
Asset Class
Equity
ETF Category
Health
Assets
729.50M
PE Ratio
20.40
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 12.31% |
| 2 | JNJ | Johnson & Johnson | 9.60% |
| 3 | ABBV | AbbVie Inc. | 6.14% |
| 4 | MRK | Merck & Co., Inc. | 4.90% |
| 5 | SWX: NOVN | Novartis AG | 4.67% |
| 6 | LON: AZN | AstraZeneca PLC | 4.61% |
| 7 | SWX: ROP | Roche Holding AG | 4.50% |
| 8 | AMGN | Amgen Inc. | 4.42% |
| 9 | GILD | Gilead Sciences, Inc. | 4.40% |
| 10 | PFE | Pfizer Inc. | 4.06% |
| 11 | BMY | Bristol-Myers Squibb Company | 3.14% |
| 12 | CPH: NOVO.B | Novo Nordisk A/S | 2.96% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 2.90% |
| 14 | EPA: SAN | Sanofi | 2.72% |
| 15 | LON: GSK | GSK plc | 2.69% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 1.98% |
| 17 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 1.48% |
| 18 | ASX: CSL | CSL Limited | 1.44% |
| 19 | ZTS | Zoetis Inc. | 1.26% |
| 20 | ETR: BAYN | Bayer Aktiengesellschaft | 1.16% |
| 21 | EBR: ARGX | argenx SE | 1.14% |
| 22 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.10% |
| 23 | EBR: UCB | UCB SA | 0.91% |
| 24 | TLV: TEVA | Teva Pharmaceutical Industries Limited | 0.89% |
| 25 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 0.87% |
As of Mar 29, 2026